US · Healthcare · Medical Devices
EPS came in at 0.10 against a street estimate of -0.26 — a beat of 138.5%.
Analysts rate Inspire Medical Systems Inc a buy (13 buy, 5 hold, 0 sell out of 18) with an average price target of $51.43.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.32% |
| Deerfield Management Co | 9.38% |
| Wellington Management Company LLP | 8.80% |
| Vanguard Portfolio Management, LLC | 5.68% |
| Morgan Stanley - Brokerage Accounts | 5.03% |
| Vanguard Capital Management, LLC | 4.40% |
| D. E. Shaw & Co LP | 4.12% |
| William Blair Investment Management, LLC | 3.95% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 | 2026-07-24 |
| Board / officer change · Q3 2026 | 2026-07-22 |
| Reg FD disclosure · Q2 2026 | 2026-06-26 |
| Board / officer change · Q2 2026 | 2026-05-05 |
| Quarterly report · Q1 2026 | 2026-05-04 |
| Proxy statement · Q2 2026 | 2026-03-20 |
| Annual report FY2025 | 2026-02-13 |
| Quarterly report · Q3 2025 | 2025-11-03 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Inspire Medical Systems Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.